| 中文名 | 4-氧代哌啶-1-羧酸异丙酯 |
|---|---|
| 英文名 | Isopropyl 4-oxo-1-piperidinecarboxylate |
| 中文别名 | 1-异丙氧羰基-4-哌啶酮 |
| 英文别名 |
4-Nitro-trans-zimtsaeure-isopropylester
isopropyl 4-oxopiperidine-1-carboxylate 4-nitro-trans-cinnamic acid isopropyl ester iso-propyl 4-nitrocinnamate 2-Propenoic acid,3-(4-nitrophenyl)-,1-methylethyl ester 4-oxopiperidine-1-carboxylic acid isopropyl ester isopropyl 3-(4-nitrophenyl)propenoate |
| 分子式 | C9H15NO3 |
|---|---|
| 分子量 | 185.22000 |
| 精确质量 | 185.10500 |
| PSA | 46.61000 |
| LogP | 1.13420 |
|
~49%
190013-27-5 |
| 文献:Mitsubishi Tanabe Pharma Corporation Patent: EP2390254 A1, 2011 ; Location in patent: Page/Page column 64 ; EP 2390254 A1 |
|
~%
190013-27-5 |
| 文献:BRISTOL-MYERS SQUIBB COMPANY Patent: WO2008/137436 A1, 2008 ; Location in patent: Page/Page column 85-86 ; WO 2008/137436 A1 |
|
~%
190013-27-5 |
| 文献:BOEHRINGER INGELHEIM INTERNATIONAL GMBH; NEUROCRINE BIOSCIENCES, INC.; NOSSE, Bernd; ECKHARDT, Matthias; HIMMELSBACH, Frank; LANGKOPF, Elke; ASHWEEK, Neil J.; HARRIOTT, Nicole Patent: WO2014/19967 A1, 2014 ; |
| 上游产品 4 | |
|---|---|
| 下游产品 0 | |